Publicaciones en las que colabora con Montserrat García Lavandeira (10)

2022

  1. LEAP-2 Counteracts Ghrelin-Induced Food Intake in a NutrientGrowth Hormone and Age Independent Manner

    Cells, Vol. 11, Núm. 3

2021

  1. RET signalling provides tumorigenic mechanism and tissue specificity for AIP-related somatotrophinomas

    Oncogene, Vol. 40, Núm. 45, pp. 6354-6368

2016

  1. Pharmacological and genetic manipulation of p53 in brown fat at adult but not embryonic stages regulates thermogenesis and body weight in male mice

    Endocrinology, Vol. 157, Núm. 7, pp. 2735-2749

2015

  1. Pituitary Cell Turnover: From Adult Stem Cell Recruitment through Differentiation to Death

    Neuroendocrinology, Vol. 101, Núm. 3, pp. 175-192

2014

  1. Somatotropinomas, but not nonfunctioning pituitary adenomas, maintain a functional apoptotic RET/Pit1/ARF/p53 pathway that is blocked by excess GDNF

    Endocrinology, Vol. 155, Núm. 11, pp. 4329-4340

2013

  1. The orexigenic effect of orexin-A revisited: Dependence of an intact growth hormone axis

    Endocrinology, Vol. 154, Núm. 10, pp. 3589-3598

2012

  1. Craniopharyngiomas express embryonic stem cell markers (SOX2, OCT4, KLF4, and SOX9) as pituitary stem cells but do not coexpress RET/GFRA3 receptors

    Journal of Clinical Endocrinology and Metabolism, Vol. 97, Núm. 1

  2. Direct promoter induction of p19Arf by Pit-1 explains the dependence receptor RET/Pit-1/p53-induced apoptosis in the pituitary somatotroph cells

    Oncogene, Vol. 31, Núm. 23, pp. 2824-2835

2009

  1. A GRFa2/Prop1/Stem (GPS) cell niche in the pituitary

    PLoS ONE, Vol. 4, Núm. 3

2007

  1. The dependence receptor Ret induces apoptosis in somatotrophs through a Pit-1/p53 pathway, preventing tumor growth

    EMBO Journal, Vol. 26, Núm. 8, pp. 2015-2028